- Business Wire•2 days agoNOVO NORDISK SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S – (NVO)
Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 13, 2017 to file lead plaintiff applications in a securities class action lawsuit against Novo Nordisk A/S , if they purchased the Company’s American Depository Receipts between the expanded period of February 5, 2015 and October 27, 2016, inclusive .
- Accesswire•2 days agoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO
NEW YORK, NY / ACCESSWIRE / February 17, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: ...
- Business Wire•3 days agoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017
The following statement is being issued by Levi & Korsinsky, LLP:
NVO : Summary for Novo Nordisk A/S Common Stock - Yahoo Finance
Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||35.19 - 35.46|
|52 Week Range||30.89 - 57.81|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.41|
|Dividend & Yield||1.12 (3.15%)|
|1y Target Est||N/A|